443 related articles for article (PubMed ID: 11857736)
1. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.
Otto F; Kanegane H; Mundlos S
Hum Mutat; 2002 Mar; 19(3):209-16. PubMed ID: 11857736
[TBL] [Abstract][Full Text] [Related]
2. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420
[TBL] [Abstract][Full Text] [Related]
3. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.
Zhang YW; Yasui N; Ito K; Huang G; Fujii M; Hanai J; Nogami H; Ochi T; Miyazono K; Ito Y
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10549-54. PubMed ID: 10962029
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia.
Lo Muzio L; Tetè S; Mastrangelo F; Cazzolla AP; Lacaita MG; Margaglione M; Campisi G
Ann Clin Lab Sci; 2007; 37(2):115-20. PubMed ID: 17522365
[TBL] [Abstract][Full Text] [Related]
5. Six novel mutations of the RUNX2 gene in Italian patients with cleidocranial dysplasia.
Tessa A; Salvi S; Casali C; Garavelli L; Digilio MC; Dotti MT; Di Giandomenico S; Valoppi M; Grieco GS; Comanducci G; Bianchini G; Fortini D; Federico A; Giannotti A; Santorelli FM
Hum Mutat; 2003 Jul; 22(1):104. PubMed ID: 12815605
[TBL] [Abstract][Full Text] [Related]
6. RUNX2 analysis of Danish cleidocranial dysplasia families.
Hansen L; Riis AK; Silahtaroglu A; Hove H; Lauridsen E; Eiberg H; Kreiborg S
Clin Genet; 2011 Mar; 79(3):254-63. PubMed ID: 20560987
[TBL] [Abstract][Full Text] [Related]
7. RUNX2 mutations in cleidocranial dysplasia patients.
Ryoo HM; Kang HY; Lee SK; Lee KE; Kim JW
Oral Dis; 2010 Jan; 16(1):55-60. PubMed ID: 19744171
[TBL] [Abstract][Full Text] [Related]
8. Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia.
Ott CE; Leschik G; Trotier F; Brueton L; Brunner HG; Brussel W; Guillen-Navarro E; Haase C; Kohlhase J; Kotzot D; Lane A; Lee-Kirsch MA; Morlot S; Simon ME; Steichen-Gersdorf E; Tegay DH; Peters H; Mundlos S; Klopocki E
Hum Mutat; 2010 Aug; 31(8):E1587-93. PubMed ID: 20648631
[TBL] [Abstract][Full Text] [Related]
9. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
10. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients.
Bufalino A; Paranaíba LM; Gouvêa AF; Gueiros LA; Martelli-Júnior H; Junior JJ; Lopes MA; Graner E; De Almeida OP; Vargas PA; Coletta RD
Oral Dis; 2012 Mar; 18(2):184-90. PubMed ID: 22023169
[TBL] [Abstract][Full Text] [Related]
11. Diversity of supernumerary tooth formation in siblings with cleidocranial dysplasia having identical mutation in RUNX2 : possible involvement of non-genetic or epigenetic regulation.
Suda N; Hamada T; Hattori M; Torii C; Kosaki K; Moriyama K
Orthod Craniofac Res; 2007 Nov; 10(4):222-5. PubMed ID: 17973689
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.
Yoshida T; Kanegane H; Osato M; Yanagida M; Miyawaki T; Ito Y; Shigesada K
Am J Hum Genet; 2002 Oct; 71(4):724-38. PubMed ID: 12196916
[TBL] [Abstract][Full Text] [Related]
13. Altered gene expression in human cleidocranial dysplasia dental pulp cells.
Chen S; Santos L; Wu Y; Vuong R; Gay I; Schulze J; Chuang HH; MacDougall M
Arch Oral Biol; 2005 Feb; 50(2):227-36. PubMed ID: 15721154
[TBL] [Abstract][Full Text] [Related]
14. Delayed tooth eruption and suppressed osteoclast number in the eruption pathway of heterozygous Runx2/Cbfa1 knockout mice.
Yoda S; Suda N; Kitahara Y; Komori T; Ohyama K
Arch Oral Biol; 2004 Jun; 49(6):435-42. PubMed ID: 15099800
[TBL] [Abstract][Full Text] [Related]
15. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.
Lee B; Thirunavukkarasu K; Zhou L; Pastore L; Baldini A; Hecht J; Geoffroy V; Ducy P; Karsenty G
Nat Genet; 1997 Jul; 16(3):307-10. PubMed ID: 9207800
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and image features, and identification of pathogenic gene mutation of two cleidocranial dysplasia families].
Wang GX; Ma LX; Xu WF; Song FL; Sun RP
Zhonghua Er Ke Za Zhi; 2010 Nov; 48(11):834-8. PubMed ID: 21215027
[TBL] [Abstract][Full Text] [Related]
17. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
18. Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation.
Jaruga A; Hordyjewska E; Kandzierski G; Tylzanowski P
Clin Genet; 2016 Nov; 90(5):393-402. PubMed ID: 27272193
[TBL] [Abstract][Full Text] [Related]
19. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.
Quack I; Vonderstrass B; Stock M; Aylsworth AS; Becker A; Brueton L; Lee PJ; Majewski F; Mulliken JB; Suri M; Zenker M; Mundlos S; Otto F
Am J Hum Genet; 1999 Nov; 65(5):1268-78. PubMed ID: 10521292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
